Transcriptomic Analysis Reveals the Protection of Astragaloside IV against Diabetic Nephropathy by Modulating Inflammation

Abstract

AS-IV treatment ameliorated the severity of DN by inhibiting inflammation-related gene expression in the kidney of rats.